Regenerative medicine is an exciting, rapidly moving field that promises to launch an entirely new industry with an entirely new product: human cells. But biology, as it is currently practiced, is not easily adapted to an industrial scale, where cost-effectiveness, throughput, and quality control are the metrics of success. For regenerative medicine to progress, new technologies must be developed to address some key questions: How can we cost-effectively expand stem cells to industrial scale quantities (on the order of 108 - 1010 per therapeutic dose) while maintaining a homogeneous pluripotent cell phenotype? How can we uniformly differentiate these cells into therapeutic phenotypes and mitigate the risk of teratoma formation? By what me...
Human mesenchymal stem cells (hMSCs) isolated from various tissues represent the most highly utilize...
For almost two decades it is claimed that cell-based therapies will revolutionize the field of medic...
One of the bottlenecks for cell therapy development is the need to isolate specific cells, be it ste...
Enabling stem cell-base therapies requires innovative solutions to close the gaps which exist betwee...
Cell-based therapies have the potential to cure currently incurable diseases by replacing missing or...
Despite their great potential in regenerative medicine applications, stem cells (especially pluripot...
The long-term view of regenerative medicine therapies predicts an increased need for expansion solut...
The next healthcare revolution will apply regenerative medicines using human cells and tissues. The ...
Human pluripotent stem cells (PSC) hold great promise as a source of starting material for the furth...
Part I - A Microfluidic Method for the Selection of Undifferentiated Human Embryonic Stem Cells and ...
The development of stem cell-derived allogeneic therapeutics requires manufacturing processes able t...
Clinical outcomes of cell therapies show their revolutionary potential in treating many diseases, an...
To study human development and disease, and develop therapies for regenerative medicine, the ability...
During the past decades, human stem cells (hSC) have emerged as a therapeutic alternative for sever...
Human embryonic stem cells (hESCs) have the potential to provide a limitless supply of somatic cells...
Human mesenchymal stem cells (hMSCs) isolated from various tissues represent the most highly utilize...
For almost two decades it is claimed that cell-based therapies will revolutionize the field of medic...
One of the bottlenecks for cell therapy development is the need to isolate specific cells, be it ste...
Enabling stem cell-base therapies requires innovative solutions to close the gaps which exist betwee...
Cell-based therapies have the potential to cure currently incurable diseases by replacing missing or...
Despite their great potential in regenerative medicine applications, stem cells (especially pluripot...
The long-term view of regenerative medicine therapies predicts an increased need for expansion solut...
The next healthcare revolution will apply regenerative medicines using human cells and tissues. The ...
Human pluripotent stem cells (PSC) hold great promise as a source of starting material for the furth...
Part I - A Microfluidic Method for the Selection of Undifferentiated Human Embryonic Stem Cells and ...
The development of stem cell-derived allogeneic therapeutics requires manufacturing processes able t...
Clinical outcomes of cell therapies show their revolutionary potential in treating many diseases, an...
To study human development and disease, and develop therapies for regenerative medicine, the ability...
During the past decades, human stem cells (hSC) have emerged as a therapeutic alternative for sever...
Human embryonic stem cells (hESCs) have the potential to provide a limitless supply of somatic cells...
Human mesenchymal stem cells (hMSCs) isolated from various tissues represent the most highly utilize...
For almost two decades it is claimed that cell-based therapies will revolutionize the field of medic...
One of the bottlenecks for cell therapy development is the need to isolate specific cells, be it ste...